DESISRendovascular treatmentischaemic strokein-stent restenosis (ISR)severe ICAS
… April 2024, 156 patients were enrolled and assigned to receive DES (n=78) or BMS (n=78). The median age was 61 years (IQR 54–67), …
7articles mentioning drugs
13drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: DES ×
DES
This drug is selected. Its supporting articles are shown below.
Articles mentioning DES
7 articles · page 1 of 1DESDouble-effect sedation
… (DDE) in justifying DES. He argues against the often justified DES under the DDE in terminally ill patients.1 In what follows, we …
DESIntracranial atherosclerotic disease (IAD)intracranial arterial stenosisneointimal hyperplasia
… treatment of intracranial arterial stenosis caused by IAD with DES or BMS at our institution between 2014 and 2022. Patients had t…
DESNIH Stroke ScaleIntracranial atherosclerotic disease (ICAD)MedtronicICADStrokeOnyx Frontier
…ve medical therapy. Recent advancements in drug-eluting stents (DES) show promise for improved efficacy in intracranial application…
DESIn-stent restenosisISRSVA ostial stenosis
…iated with the development of ISRS.Conclusion Re-treatment with DES or DCB is shown to be a safe and effective treatment for managi…
83.2%
Drug Eluting StentDrug Eluting Stent (DES)DESCalderdale Royal HospitalSmall vessel diseaseIn-stent Restenosisin-stent restenosis (ISR)Ischaemic Heart DiseaseChronic kidney diseaseDiabetes mellitus78
… (LVSD)89 (40.3)Ischaemic Heart Disease (IHD)105 (47.5)Previous Drug Eluting Stent (DES)72 (32.6)Chronic kidney disease (CKD)9 (12.2)Coronary Arte…